Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
egfrviii-specific hinge-optimized cd3 ζ-stimulatory/41bb-co-stimulatory chimeric antigen receptor autologous t-lymphocytes (1 trial)
ertapenem (invanz) (2 trials)
levofloxacin (levaquin) (1 trial)
metronidazole (flagyl) (1 trial)
moxifloxacin (avelox) (2 trials)
Trials (3 total)
Trial APIs (5 total)